AU Patent

AU2023200785A1 — Methods of reducing the risk of cardiovascular events in a subject

Assigned to Amarin Pharmaceuticals Ireland Ltd · Expires 2023-03-09 · 3y expired

What this patent protects

OF THE DISCLOSURE In various embodiments, the present disclosure provides methods reducing the risk of cardiovascular events in a subject on statin therapy by administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid …

USPTO Abstract

OF THE DISCLOSURE In various embodiments, the present disclosure provides methods reducing the risk of cardiovascular events in a subject on statin therapy by administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023200785A1
Jurisdiction
AU
Classification
—
Expires
2023-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Amarin Pharmaceuticals Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.